Giangregorio Nicola, Tonazzi Annamaria, Indiveri Cesare, Palmieri Ferdinando
Department of Pharmaco-Biology, Laboratory of Biochemistry and Molecular Biology, University of Bari, 70125, Bari, Italy.
Biochim Biophys Acta. 2007 Nov;1767(11):1331-9. doi: 10.1016/j.bbabio.2007.08.010. Epub 2007 Sep 18.
During substrate translocation mitochondrial carriers cycle between the cytoplasmic-state (c-state) with substrate-binding site open to the intermembrane space and matrix-state (m-state) with the binding site open to the mitochondrial matrix. Here, the accessibility of Cys-58, Cys-136 and Cys-155 of the rat mitochondrial carnitine/acylcarnitine carrier (CAC) to membrane-impermeable SH reagents was examined as a function of the conformational state. Reconstituted mutant CACs containing the combinations Cys-58/Cys-136, Cys-58/Cys-155, and Cys-136/Cys-155 transport carnitine with a ping-pong mechanism like the wild-type, since increasing substrate concentrations on one side of the membrane decreased the apparent affinity for the substrate on the other side. In view of this mechanism, the effect of SH reagents on the transport activity of mutant CACs was tested by varying the substrate concentration inside or outside the proteoliposomes, keeping the substrate concentration on the opposite side constant. The reagents MTSES, MTSEA and fluorescein-5-maleimide did not affect the carnitine/carnitine exchange activity of the mutant carrier with only Cys-58 in contrast to mutant carriers with Cys-58/Cys-136, Cys-58/Cys-155 or Cys-136/Cys-155. In the latter, the inhibitory effect of the reagents was more pronounced when the intraliposomal carnitine concentration was increased, favouring the m-state of the carrier, whereas the effect was less when the concentration of carnitine was increased in the external compartment of the proteoliposomes, favouring the c-state. Moreover, the mutant carrier proteins with Cys-136/Cys-155, Cys-58/Cys-136 or Cys-58/Cys-155 were more fluorescent when extracted from fluorescein-5-maleimide-treated proteoliposomes containing 15 mM internal carnitine as compared to 2.5 mM. These results are discussed in terms of conformational changes of the carrier occurring during substrate translocation.
在底物转运过程中,线粒体载体在细胞质状态(c态)和基质状态(m态)之间循环,在c态时底物结合位点朝向膜间隙开放,在m态时结合位点朝向线粒体基质开放。在此,研究了大鼠线粒体肉碱/酰基肉碱载体(CAC)的半胱氨酸-58(Cys-58)、半胱氨酸-136(Cys-136)和半胱氨酸-155(Cys-155)对膜不透性巯基试剂的可及性与构象状态的关系。含有Cys-58/Cys-136、Cys-58/Cys-155和Cys-136/Cys-155组合的重组突变体CACs像野生型一样以乒乓机制转运肉碱,因为膜一侧底物浓度增加会降低其对另一侧底物的表观亲和力。鉴于此机制,通过改变蛋白脂质体内外的底物浓度,同时保持另一侧底物浓度恒定,来测试巯基试剂对突变体CACs转运活性的影响。与含有Cys-58/Cys-136、Cys-58/Cys-155或Cys-136/Cys-155的突变体载体相比,试剂MTSES、MTSEA和荧光素-5-马来酰亚胺对仅含有Cys-58的突变体载体的肉碱/肉碱交换活性没有影响。在后者中,当脂质体内肉碱浓度增加时,有利于载体处于m态,试剂的抑制作用更明显;而当蛋白脂质体外部隔室中肉碱浓度增加时,有利于载体处于c态,其作用则较小。此外,与含有2.5 mM内部肉碱的荧光素-5-马来酰亚胺处理的蛋白脂质体相比,从含有15 mM内部肉碱的荧光素-5-马来酰亚胺处理的蛋白脂质体中提取的含有Cys-136/Cys-155、Cys-58/Cys-136或Cys-58/Cys-155的突变体载体蛋白荧光更强。根据底物转运过程中载体的构象变化对这些结果进行了讨论。